Industries · Medtech

AI Visibility for Medtech

A regulated claim a model cannot verify is a claim it will decline to repeat, which is the correct behaviour and a real commercial problem.

27/100
Average AI visibility score for medtech
Neurock AI Visibility Index
5
Dimensions scored: structure, answer density, trust, accessibility, authority
Neurock audit methodology
4
Assistants tested: ChatGPT, Perplexity, Claude, Google AI Overviews
Neurock AI Visibility Index
What buyers ask
The questions

Where the shortlist gets decided

These are the shapes of question an assistant is asked in your category. Each one produces a short list of names, and that list is the whole competition.

  • Which devices are approved for [indication] in Europe
  • What are the alternatives to [incumbent device]
  • Which supplier meets MDR requirements for [category]
Why it matters
The stakes

Medtech sits at 27 out of 100

Medtech buyers are procurement committees and clinicians, both of whom now use assistants to narrow options before formal evaluation. Assistants are also deliberately conservative about health claims, so unverifiable positioning is not merely ignored, it is actively filtered.

Where the gap is

Regulatory status, indications, and evidence buried in gated documents. The exact material that would make a model confident enough to name you is the material most often placed behind a form.

NOTE The score is the measured average for medtech in the Neurock AI Visibility Index, not an estimate for any single company. Your own position is measured in the audit.
Get your own score

Find out where you stand

When a buyer asks an assistant who to work with, it names two or three companies and moves on. The audit puts the questions your buyers actually ask to all five AI platforms, scores you on the five things a model weighs before it cites anyone, and shows you which competitor is named in your place. You get the gap and the order to close it in, five business days from briefing.